Trial Profile
An Open Label Randomized Comparative Study to Assess the Efficacy and Tolerability of Eurartesim Versus Chloroquine and Nonrelapse Therapy With Primaquine for Uncomplicated Plasmodium Vivax Monoinfection Malaria
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 13 Jun 2023
Price :
$35
*
At a glance
- Drugs Dihydroartemisinin/piperaquine (Primary) ; Chloroquine; Primaquine
- Indications Vivax malaria
- Focus Therapeutic Use
- Acronyms CuraVivax
- 25 Apr 2023 Status changed from active, no longer recruiting to completed.
- 25 Oct 2021 Planned End Date changed from 1 Jun 2021 to 1 Mar 2022.
- 25 Oct 2021 Status changed from recruiting to active, no longer recruiting.